Skip to main content

Marat Fudim

Associate Professor of Medicine
Medicine, Cardiology

Current Duke Appointments & Affiliations


Associate Professor of Medicine · 2023 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2020 - Present Duke Clinical Research Institute, Institutes and Centers

Recent News Items


Published May 16, 2024
Study Shows Rise in Heart Failure Deaths in Younger Adults
Published September 1, 2022
Out of the Hospital, But Not Out of the Woods

View All News Items

Recent Scholarly Works


Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

Journal article Int J Cardiol · October 15, 2026 BACKGROUND: Ischemic heart disease (IHD) presents a growing global health burden across diverse geographic and socioeconomic settings. Clinical practice guidelines are typically developed by professional societies in high-income countries, often with limit ... Full text Link to item Cite

Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence.

Journal article Circ Heart Fail · August 19, 2026 Cardiovascular disease remains a major cause of morbidity and mortality, with heart failure representing the common and often irreversible end stage, for which current therapies are largely palliative rather than restorative. Cardiac microcurrent therapy d ... Full text Link to item Cite

Central Adiposity, Systemic Inflammation, and Incident Heart Failure: A Causal Mediation Analysis From the Jackson Heart Study.

Journal article J Am Heart Assoc · August 4, 2026 BACKGROUND: Obesity and systemic inflammation have each been independently associated with an increased risk of heart failure (HF). However, whether inflammatory pathways mediate the association between obesity and the development of heart failure remains ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


A Multicenter, Open-label, Long-term Extension Study for Oral Levosimendan (TNX-103)

Clinical TrialPrincipal Investigator · Awarded by Tenax Therapeutics, Inc. · 2026 - 2036

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Clinical TrialPrincipal Investigator · Awarded by Vasa Therapeutics, Inc. · 2026 - 2035

DCA08 HS235-003

Clinical TrialPrincipal Investigator · Awarded by 35Pharma Inc. · 2025 - 2035

View All Grants

Education


University of Düsseldorf (Germany) · 2011 M.D.